PMID- 32380873
OWN - NLM
STAT- MEDLINE
DCOM- 20210426
LR  - 20220415
IS  - 1747-4132 (Electronic)
IS  - 1747-4124 (Linking)
VI  - 14
IP  - 6
DP  - 2020 Jun
TI  - Insights and updates on endoscopic papillectomy.
PG  - 435-444
LID - 10.1080/17474124.2020.1766965 [doi]
AB  - INTRODUCTION: Endoscopic papillectomy (EP) has been established as a useful 
      endoscopic therapy by the efforts of many pancreatobiliary endoscopists and is 
      presently accepted as a reliable alternative therapy to surgery in patients with 
      ampullary adenoma. Moreover, there have been numerous advancements in EP 
      techniques in recent years. Various approaches and attempts toward expanding the 
      indications of endoscopic resection have been reported. Furthermore, the 
      management and prevention of adverse events (AEs) and endoscopic treatment for 
      remnant or recurrent lesions have also been reported. In the present review, we 
      focus on recent advancements in the EP technique, as well as speculate on the 
      future issues of EP. AREA COVERED: This review of EP encompasses the indications, 
      preoperative assessments, endoscopic techniques, outcomes, and AEs of EP, post-EP 
      surveillance techniques, and treatments for remnant or recurrence lesions. EXPERT 
      OPINION: The ultimate goal of EP is the complete resection of ampullary tumors, 
      regardless of whether they are adenomatous or carcinomatous lesions, without 
      causing any AEs. Therefore, the most important issue is preoperative evaluation, 
      that is, the accurate diagnosis of lesions contraindicated for EP. In addition, 
      further research on the prevention of AEs is also necessary towards establishing 
      EP as a safe endoscopic procedure.
FAU - Yamamoto, Kenjiro
AU  - Yamamoto K
AD  - Department of Gastroenterology and Hepatology, Tokyo Medical University , Tokyo, 
      Japan.
FAU - Iwasaki, Eisuke
AU  - Iwasaki E
AD  - Division of Gastroenterology and Hepatology, Department of Internal Medicine, 
      Keio University School of Medicine , Tokyo, Japan.
FAU - Itoi, Takao
AU  - Itoi T
AD  - Department of Gastroenterology and Hepatology, Tokyo Medical University , Tokyo, 
      Japan.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20200522
PL  - England
TA  - Expert Rev Gastroenterol Hepatol
JT  - Expert review of gastroenterology & hepatology
JID - 101278199
SB  - IM
MH  - Adenoma/diagnosis/*surgery
MH  - Ampulla of Vater/*surgery
MH  - Common Bile Duct Neoplasms/diagnosis/*surgery
MH  - Digestive System Surgical Procedures/adverse effects/methods/trends
MH  - Duodenoscopy
MH  - Forecasting
MH  - Humans
MH  - Perioperative Care
MH  - Precancerous Conditions/diagnosis/*surgery
MH  - *Sphincterotomy, Endoscopic/adverse effects/methods/trends
OTO - NOTNLM
OT  - Ampullary adenomas
OT  - ampullary carcinoma
OT  - endoscopic ablative therapy
OT  - endoscopic papillectomy
OT  - endoscopic ultrasonography
OT  - familial adenomatous polyposis
OT  - intraductal radiofrequency ablation
OT  - intraductal ultrasonography
OT  - post-EP pancreatitis
OT  - prophylactic pancreatic stent
EDAT- 2020/05/10 06:00
MHDA- 2021/04/27 06:00
CRDT- 2020/05/09 06:00
PHST- 2020/05/10 06:00 [pubmed]
PHST- 2021/04/27 06:00 [medline]
PHST- 2020/05/09 06:00 [entrez]
AID - 10.1080/17474124.2020.1766965 [doi]
PST - ppublish
SO  - Expert Rev Gastroenterol Hepatol. 2020 Jun;14(6):435-444. doi: 
      10.1080/17474124.2020.1766965. Epub 2020 May 22.